Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (8 quarters reported)
$52.5M in Q4 2014 → $50.2M now. Hover for any quarter.
As reported for the quarter ended September 30, 2016. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| RT Revance Therapeutics, Inc. | 100.0% | Unchanged | 3,096,650 | $50.2M |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 7 quarters.
quarter ended September 30, 2016 · filed October 27, 2016
No position changes this quarter.
quarter ended June 30, 2016 · filed July 26, 2016
No position changes this quarter.
quarter ended March 31, 2016 · filed April 25, 2016
No position changes this quarter.
quarter ended December 31, 2015 · filed February 09, 2016
No position changes this quarter.
quarter ended September 30, 2015 · filed October 13, 2015
No position changes this quarter.
quarter ended June 30, 2015 · filed August 03, 2015
No position changes this quarter.
quarter ended March 31, 2015 · filed April 28, 2015
No position changes this quarter.
Loading...
